DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+19.39%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$140M
AUM Growth
+$140M
(+19%)
Cap. Flow
+$11.3M
Cap. Flow
% of AUM
8.03%
Top 10 Holdings %
Top 10 Hldgs %
48%
Holding
83
New
9
Increased
22
Reduced
17
Closed
8
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$3.4M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$3.15M |
| 3 |
Sangamo Therapeutics
SGMO
|
$1.98M |
| 4 |
Minerva Neurosciences
NERV
|
$1.55M |
| 5 |
DERM
Dermira, Inc.
DERM
|
$1.38M |
Top Sells
| 1 |
AtriCure
ATRC
|
$2.98M |
| 2 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$1.75M |
| 3 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$747K |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
$398K |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$369K |
Sector Composition
| 1 | Healthcare | 80.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Voyager Therapeutics
VYGR
$204M
| $1.84M | 1.31% |
204,808
+133,488
| +187% | +$1.2M |
|
|
FOMX
27
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.65M | 1.18% |
355,667
+30,000
| +9% | +$139K |
|
|
ADXS
28
DELISTED
Advaxis, Inc.
ADXS
| $1.6M | 1.14% |
16,467
+5,000
| +44% | +$487K |
|
29
Cidara Therapeutics
CDTX
$1.61B
| $1.56M | 1.12% |
10,423
| – | – |
|
|
NEOS
30
DELISTED
Neos Therapeutics, Inc
NEOS
| $1.53M | 1.09% |
209,873
+114,600
| +120% | +$837K |
|
31
Spyre Therapeutics
SYRE
$1.02B
| $1.35M | 0.96% |
13,984
-32
| -0.2% | -$3.08K |
|
32
uniQure
QURE
$954M
| $1.26M | 0.9% |
203,907
| – | – |
|
33
Johnson & Johnson
JNJ
$429B
| $1.24M | 0.89% |
9,400
| – | – |
|
|
ACHN
34
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $1.22M | 0.87% |
266,500
+70,000
| +36% | +$321K |
|
35
Rigel Pharmaceuticals
RIGL
$710M
| $1.21M | 0.86% |
44,348
-3,000
| -6% | -$81.9K |
|
36
Xenon Pharmaceuticals
XENE
$2.99B
| $1.19M | 0.85% |
377,695
+38,081
| +11% | +$120K |
|
|
NDRM
37
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $1.13M | 0.81% |
37,938
+500
| +1% | +$14.9K |
|
|
ARQL
38
DELISTED
Arqule Inc
ARQL
| $973K | 0.69% |
784,508
-22,500
| -3% | -$27.9K |
|
|
ELOS
39
DELISTED
Syneron Medical Ltd
ELOS
| $941K | 0.67% |
85,947
| – | – |
|
40
Ascendis Pharma
ASND
$12.1B
| $922K | 0.66% |
33,214
+15,000
| +82% | +$416K |
|
41
SCYNEXIS
SCYX
$35.2M
| $907K | 0.65% |
50,690
+12,500
| +33% | +$224K |
|
42
argenx
ARGX
$44.2B
| $848K | 0.61% |
+40,000
| New | +$848K |
|
|
BLUE
43
DELISTED
bluebird bio
BLUE
| $840K | 0.6% |
618
-77
| -11% | -$105K |
|
|
BLRX
44
BioLineRX
BLRX
$15.5M
| $828K | 0.59% |
1,634
-33
| -2% | -$16.7K |
|
|
ZGNX
45
DELISTED
Zogenix, Inc.
ZGNX
| $809K | 0.58% |
55,809
-3,969
| -7% | -$57.5K |
|
46
Stereotaxis
STXS
$247M
| $796K | 0.57% |
1,372,862
| – | – |
|
|
EXAC
47
DELISTED
Exactech Inc
EXAC
| $689K | 0.49% |
23,136
-8,500
| -27% | -$253K |
|
|
CGNT
48
DELISTED
Cogentix Medical, Inc.
CGNT
| $615K | 0.44% |
353,482
| – | – |
|
49
Tandem Diabetes Care
TNDM
$834M
| $579K | 0.41% |
72,429
| – | – |
|
50
Rocket Pharmaceuticals
RCKT
$358M
| $451K | 0.32% |
59,284
| – | – |
|